The Effects of Celecoxib on Bone Ingrowth

Stopped early · Early Phase 1

Conditions studied: Bone Ingrowth, Pain

In brief

The purpose of this study is to evaluate the effect of Celebrex on bone growth into porous coated implants, following postoperative total knee arthroplasty administration of Celebrex for pain relief.

Key facts

Study ID

NCT00585156

Run by

University of Utah

People needed

9

Starts

2008-06-01

Expected to finish

2008-09-01

Last updated by the study team

2016-03-14

Who can join

Age: 18 and older, up to 95. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Male VA bilateral TKA patients 18 years or older with primary OA diagnosis

You may not qualify if…

• Patients with osteoporosis, hypersensitivity to Celebrex, allergy to tetracycline, Sulfonamides, patient with asthma, urticaria, or allergic-type reactions to aspirin or NSAIDs.
• Patients who have had CABG.
• Patients with a history of peptic ulcer disease, duodenal ulcers.
• Female patients and patients diagnosed with unstable hypertension or hypotensive, with serum creative levels above 1.8-2.0 or diagnosed with severe renal disease.

Where it is running

• Veteran Affairs (VA) Medical Center — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.